Advertisement

Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 800–801 | Cite as

ASO Author Reflections: Serum Elastase 1 Level as a Risk Factor for Postoperative Recurrence in Patients with Well-Differentiated Pancreatic Neuroendocrine Neoplasms

  • Yoshihide Nanno
  • Hirochika Toyama
ASO Author Reflections
  • 65 Downloads

Notes

Disclosure

All authors declare that they have no conflict of interest.

References

  1. 1.
    Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9:61–72.CrossRefGoogle Scholar
  2. 2.
    Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–72.CrossRefGoogle Scholar
  3. 3.
    Nanno Y, Matsumoto I, Zen Y, et al. Pancreatic duct involvement in well-differentiated neuroendocrine tumors is an independent poor prognostic factor. Ann Surg Oncol. 2017;24:1127–33.CrossRefGoogle Scholar
  4. 4.
    Nanno Y, Toyama H, Zen Y, et al. Serum elastase 1 level as a risk factor for postoperative recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasms. Ann Surg Oncol. 2018 (in press)  https://doi.org/10.1245/s10434-forthcoming.

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Division of Hepato-Biliary-Pancreatic SurgeryKobe University Graduate School of MedicineKobeJapan

Personalised recommendations